• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特纳综合征的生长:低剂量炔雌醇的长期治疗。

Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.

作者信息

Martínez A, Heinrich J J, Domené H, Escobar M E, Jasper H, Montuori E, Bergadá G

出版信息

J Clin Endocrinol Metab. 1987 Aug;65(2):253-7. doi: 10.1210/jcem-65-2-253.

DOI:10.1210/jcem-65-2-253
PMID:3597706
Abstract

The growth response to 100 ng/kg BW X day ethinyl estradiol (2-4 micrograms/day) given for 18 months was studied in a group of nine patients with Turner's syndrome, aged 8.6-13.3 yr. All patients were prepubertal and had elevated gonadotropin levels. Growth velocity increased from 3.09 +/- 1.05 (+/-SD) to 7.09 +/- 1.47 cm/yr in the first 6 months, 6.08 +/- 1.78 cm/yr in the second 6 months, and 4.03 +/- 1.65 cm/yr in the third 6 months. Bone age increased a mean of 0.82 +/- 0.34, 0.89 +/- 0.79, and 0.74 +/- 0.59 yr, respectively, in the three 6-month periods. Predicted height prognosis did not change after any period. All patients had pubertal changes, limited in most to slight breast development. Mean diurnal spontaneous GH secretion did not change during treatment. Plasma somatomedin-C levels were low before treatment, and ethinyl estradiol did not significantly increase somatomedin-C values. Our data confirm the ability of a low dose of ethinyl estradiol to increase growth velocity in girls with Turner's syndrome, although the effect diminished with time, and the excess bone age advancement precluded improvement of predicted height.

摘要

对一组9名年龄在8.6至13.3岁的特纳综合征患者,研究了给予100 ng/kg体重/天乙炔雌二醇(2 - 4微克/天)持续18个月后的生长反应。所有患者均为青春期前,促性腺激素水平升高。生长速度在前6个月从3.09±1.05(±标准差)厘米/年增加到7.09±1.47厘米/年,在第二个6个月为6.08±1.78厘米/年,在第三个6个月为4.03±1.65厘米/年。在三个6个月期间,骨龄分别平均增加0.82±0.34、0.89±0.79和0.74±0.59岁。任何时期后预测身高预后均未改变。所有患者均有青春期变化,大多数仅限于轻微乳房发育。治疗期间平均日自发性生长激素分泌未改变。治疗前血浆生长调节素-C水平较低,乙炔雌二醇未显著增加生长调节素-C值。我们的数据证实了低剂量乙炔雌二醇能增加特纳综合征女孩的生长速度,尽管效果随时间减弱,且骨龄提前过多妨碍了预测身高的改善。

相似文献

1
Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.特纳综合征的生长:低剂量炔雌醇的长期治疗。
J Clin Endocrinol Metab. 1987 Aug;65(2):253-7. doi: 10.1210/jcem-65-2-253.
2
Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.使用生长激素和氧雄龙治疗的特纳综合征女孩最终身高得到改善。
J Clin Endocrinol Metab. 1996 Feb;81(2):635-40. doi: 10.1210/jcem.81.2.8636281.
3
Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.生长激素和低剂量炔雌醇对特纳综合征女孩的促生长作用。
J Clin Endocrinol Metab. 1990 Jan;70(1):122-6. doi: 10.1210/jcem-70-1-122.
4
Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.急性大剂量和慢性小剂量雌激素对特纳综合征患者血浆生长调节素C及生长的影响。
J Clin Endocrinol Metab. 1988 Jun;66(6):1278-82. doi: 10.1210/jcem-66-6-1278.
5
Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.低剂量乙炔雌二醇给药对患有特纳综合征的青春期前女孩生长激素、促卵泡激素和促黄体生成素脉冲式释放的特异性、时间依赖性作用。
J Clin Endocrinol Metab. 1989 Nov;69(5):1053-8. doi: 10.1210/jcem-69-5-1053.
6
Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.自然青春期或诱导青春期对特纳综合征女孩生长激素治疗生长促进作用的影响。
Clin Endocrinol (Oxf). 1993 Mar;38(3):253-60. doi: 10.1111/j.1365-2265.1993.tb01003.x.
7
The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.生长激素和炔雌醇短期治疗对特纳综合征女孩小腿生长速率的影响。
J Clin Endocrinol Metab. 1988 Sep;67(3):515-8. doi: 10.1210/jcem-67-3-515.
8
Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.特纳综合征患者在重组人生长激素和炔雌醇治疗前及治疗期间的血清生长激素(GH)结合蛋白和胰岛素样生长因子-I水平。
J Clin Endocrinol Metab. 1992 Nov;75(5):1298-302. doi: 10.1210/jcem.75.5.1430092.
9
Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.生长激素(GH)治疗特纳综合征患者的最终身高:高剂量单独使用GH及晚期雌激素治疗的指征。意大利特纳综合征研究组
J Clin Endocrinol Metab. 1999 Dec;84(12):4510-5. doi: 10.1210/jcem.84.12.6175.
10
Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.重组生长激素治疗特纳综合征患儿时胰岛素样生长因子-I、前胶原-III N端延长肽、骨钙素和骨矿物质含量变化的比较研究
J Clin Endocrinol Metab. 1990 Dec;71(6):1461-7. doi: 10.1210/jcem-71-6-1461.